Leqembi is indicated for the treatment of ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

Biogen and Eisai have hit another bump in their quest to win European regulatory approval of their Alzheimer's drug Leqembi. The companies on Friday said the European Commission has asked the ...